KIMBRELLE PASCUA: Open Payments
NPI 1285112615 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 71 payments from 17 companies in 2025. Trend: 2023 $591 · 2024 $507 · 2025 $1,736
Food & beverage: $1,652Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $550 |
| Biocon Biologics Inc | 2 | $185 |
| Aimmune Therapeutics, Inc. | 6 | $182 |
| Janssen Biotech, Inc. | 6 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $88 |
| Intercept Pharmaceuticals, Inc. | 4 | $75 |
| QOL Medical, LLC | 3 | $73 |
| PFIZER INC. | 3 | $71 |
| Madrigal Pharmaceuticals | 2 | $62 |
| Phathom Pharmaceuticals, Inc. | 4 | $55 |
Products named: SKYRIZI, RINVOQ, Yesintek, TREMFYA, VOWST, ZENPEP, OCALIVA, Sucraid.
Industry payments across NV — which companies pay providers there.
